Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Pipeline
IMMray™ Platform
Pipeline
Learn more
Lung cancer
Autoimmune disease
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Media resources
Partnering
Contact Us
Immunovia Inc
English
Svenska
Press releases
Show
All
Regulatory
R = Regulatory
February 17, 2021
Immunovia Full Year Report 2020
R
February 15, 2021
Immunovia’s PanFAM-1 Prospective Study Gathers Over 3000 Familial...
February 11, 2021
Invitation to presentation of Immunovia’s Full Year Report 2020 on...
February 10, 2021
Immunovia On Track For IMMray™ PanCan-d Sales Start In Q1 2021
January 19, 2021
Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants
January 7, 2021
Proteomic data derived from Immunovia’s IMMray™-platform allows...
December 14, 2020
Immunovia publishes link to Webinar No. 3 on IMMray™ PanCan-d:...
December 11, 2020
Immunovia to Host a Third Webinar in the Series on IMMray™...
December 7, 2020
Immunovia Announces Investor Relations Changes
December 3, 2020
Members of Immunovia’s Board of Directors purchase shares in the...
December 2, 2020
Invitation to telephone conference in response to Dagens Industri’s ...
R
November 17, 2020
Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares
R
<
1
2
3
4
5
…
20
>
Home
Press releases
Page 3
